![](/img/cover-not-exists.png)
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses
Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger,Volume:
111
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.504
Date:
November, 2014
File:
PDF, 195 KB
english, 2014